10900 University Blvd
Manassas, VA 20110

Our Mission

Our mission is to develop anti-inflammatory and immune-modulating drugs for treatment of a broad range of inflammatory, autoimmune and infectious diseases

News


Manassas, Va. June 2013

Serpin Pharma is selected to present its recent diabetes data at the annual meeting of the European Association for the Study of Diabetes.


Manassas, Va. June 2013

Serpin Pharma attends BioMed, Israel, to present its lead drug candidate to potential partners and investors


Manassas, Va. May 2013

Serpin Pharma is awarded a CRCF award from the Center for Innovative Technology.


Manassas, Va. May 2013

Serpin Pharma is delighted to announce that Mr. Guy Yachin has joined as President & CEO. Mr. Yachin will also join Serpin Pharma’s Board of Directors.


Manassas, Va. December 2012

Serpin Pharma is awarded a phase I SBIR grant to develop SP16 for treatment of type I diabetes.


Manassas, Va. November 2012

Serpin Pharma attends BioEurope to present its lead drug candidate to potential partners.